The Europe Blood Screening
Market size
is expected to reach USD 1.17 billion by 2025 according to a new report by
Grand View Research, Inc. The market is expected to record a CAGR of 7.7%
during the forecast period. Increasing number of blood transfusion processes
performed along with stringent regulations in Europe mandating screening tests,
such as NAT for testing HIV, HBV, and HCV, is contributing to the market
growth.
Moreover,
growth in the overall number of complex surgeries that require a large amount
of blood and blood products along with rising cases of road accidents is
expected to drive the market further. Additionally, import of products through
contract agreements and development in the product technology by manufacturers
of blood screening reagents and instruments are contributing to market
expansion in the region.
For
example, DiaSystem Scandinavia AB signed a distribution agreement with SNIBE,
an Asian immunology test producer that focuses on immunoassay analyzers based
on CLIA technology. DiaSystem specializes in the production and supply of
reagents used in chemistry and immunoturbidimetry. This agreement has provided
the former company with automated chemiluminescence instrument delivering a
complete analytical system in areas, such as thyroid, renal function, hepatitis,
and hepatic fibrosis.
Browse
Details of Report @ https://www.grandviewresearch.com/industry-analysis/europe-blood-screening-market/
Further key findings from the study suggest:
- NAT led the
technology segment in 2017 owing to a regulatory obligation for mandatory
NAT screening for all blood donations.
- On the basis
of product, reagents led the Europe blood screening market in 2017
- Germany held
a majority of the market share in 2017 due to large number of blood
donors.
- Moreover,
stringent regulations in the country for screening of donations also
contributed to its growth. The Paul-Ehrlich-Institut, a medical regulatory
body in Germany, mandates NAT testing for HCV and HIV for all blood
donations.
- Roche
Diagnostics; Bio-Rad Laboratories, Inc.; Siemens Healthcare GmbH; Grifols,
S.A.; Becton, Dickinson and Company; Agilent Technologies; Thermo Fisher
Scientific, Inc.; and Danaher Corp. are some of the key companies
operating in this market.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment